𝔖 Bobbio Scriptorium
✦   LIBER   ✦

598 ORAL Randomised comparison of 5-FU/folinic acid plus irinotecan (FOLFIRI) and irinotecan plus oxaliplatin (IROX) in first-line therapy of metastatic colorectal cancer (CRC): the fire-trial

Book ID
118623175
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
131 KB
Volume
3
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

FOLFOXIRI (folinic acid, 5-fluorouracil,
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)
✍ Souglakos, J; Androulakis, N; Syrigos, K; Polyzos, A; Ziras, N; Athanasiadis, A; πŸ“‚ Article πŸ“… 2006 πŸ› Nature Publishing Group 🌐 English βš– 128 KB
Comparison the efficacy of second-line m
Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen
✍ Mehmet Ali Nahit Sendur,Nuriye Ozdemir,Tahsin Γ–zatlΔ±,Ozan YazΔ±cı… πŸ“‚ Article πŸ“… 2014 πŸ› Springer US 🌐 English βš– 630 KB